Severe anemia with Sofosbuvir based therapy for Hepatitis C (HCV) recurrence post Liver transplantation on mycophenolate mofetil (MMF)

被引：0
|
作者：
Elsiesy, Hussien [1 ]
Ajlan, Aziza A. [1 ]
Aljedai, Ahmed [1 ]
Alarieh, Rania [1 ]
Al-Hamoudi, Waleed K. [1 ,2 ]
Alkortas, Delal [1 ]
Al Sebayel, Mohammed [1 ]
Broering, Dieter C. [1 ]
Abaalkhail, Faisal A. [1 ]
机构：
[1] King Faisal Specialist Hosp D, Riyadh, Saudi Arabia
[2] King Saud Univ, Riyadh, Saudi Arabia
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1032
引用
收藏
页码：702A / 703A
页数：2
相关论文
共 50 条
  • [21] LIVE DONOR LIVER TRANSPLANTATION IS NOT ASSOCIATED WITH MORE SEVERE RECURRENCE OF HEPATITIS C (HCV)
    Simpson, M. A.
    Khettry, U.
    Gordon, F. D.
    Pomposelli, J. J.
    Pomfret, E. A.
    [J]. LIVER TRANSPLANTATION, 2008, 14 (07) : S209 - S209
  • [22] Efficacy of Sofosbuvir Based Therapy for Recurrent Hepatitis C After Liver Transplantation
    Weick, A.
    George, K.
    Jafri, S. -M.
    Moonka, D.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [23] Hepatitis C recurrence (HCVR) in liver transplant recipients (OLT) under mycophenolate mofetil (MMF) immunosuppression (IS): A long-term follow up
    Fasola, CG
    Netto, GJ
    Sanchez, EQ
    Chinnakotla, S
    Levy, MF
    Goldstein, RM
    Klintmalm, GB
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 356 - 356
  • [24] HCV genotypes and severe hepatitis C recurrence after liver transplantation: Report on 103 cases
    Alberti, AB
    Belli, LS
    Silini, E
    Bellati, G
    Asti, M
    dAmico, M
    Rondinara, GF
    Forti, D
    Ideo, G
    [J]. HEPATOLOGY, 1996, 24 (04) : 683 - 683
  • [25] The impact of immunosuppressant therapy on the recurrence of hepatitis C post-liver transplantation
    Albekairy, Abdulkareem M.
    Abdel-Razaq, Wesam S.
    Alkatheri, Abdulmalik M.
    Al Debasi, Tariq M.
    Al Otaibi, Nouf E.
    Qandil, Amjad M.
    [J]. INTERNATIONAL JOURNAL OF HEALTH SCIENCES-IJHS, 2018, 12 (04): : 78 - 87
  • [26] THE POSITIVE EFFECT OF MYCOPHENOLATE MOFETIL ON THE HISTOLOGY COURSE OF HEPATITIS C AFTER LIVER TRANSPLANTATION
    Manzia, Tommaso Maria
    Toti, Luca
    Lenci, Ilaria
    Angelico, Roberta
    Monaco, Andrea
    Manuelli, Matteo
    de Luca, Linda
    Tariciotti, Laura
    Tisone, Giuseppe
    [J]. TRANSPLANT INTERNATIONAL, 2009, 22 : 114 - 115
  • [27] Mycophenolate Mofetil Monotherapy in Patients Who Underwent Liver Transplantation for Hepatitis C Cirrhosis
    Manriclue, A.
    Jimenez, C.
    Ortega, P.
    Abradelo, M.
    Gimeno, A.
    Calvo, J.
    Carribra, F.
    L-Sterup, R.
    Morales, J. M.
    Moreno, E.
    [J]. TRANSPLANTATION PROCEEDINGS, 2008, 40 (09) : 2962 - 2964
  • [28] Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence
    Poordad, Fred
    Schiff, Eugene R.
    Vierling, John M.
    Landis, Charles
    Fontana, Robert J.
    Yang, Rong
    McPhee, Fiona
    Hughes, Eric A.
    Noviello, Stephanie
    Swenson, Eugene S.
    [J]. HEPATOLOGY, 2016, 63 (05) : 1493 - 1505
  • [29] Hepatitis C virus (HCV) recurrence is an early and severe event in living donor liver transplantation (LDLT).
    Garcia-Retortillo, M
    Forns, X
    Llovet, JM
    Navasa, M
    Massaguer, A
    Feliu, A
    Bruguera, M
    Fuster, J
    Garcia-Valdecasas, JC
    Rimola, A
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 294 - 294
  • [30] Hepatitis C virus (HCV) recurrence is an early and severe event in living donor liver transplantation (LDLT)
    Garcia-Retortillo, M
    Forns, X
    Llovet, JM
    Navasa, M
    Massaguer, A
    Feliu, A
    Bruguera, M
    Fuster, J
    Garcia-Valdecasas, JC
    Rimola, A
    [J]. JOURNAL OF HEPATOLOGY, 2004, 40 : 3 - 3
12345